Suzanne Nora Johnson

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencecorroborated
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

Seats held as a director, as published in the cited sources.

1. 2026 to end not published
   Executive title: PresidentOrganization not published
   E1
2. 2026 to end not published
   Executive title: Executive Vice President, Chief Administrative Officer and Chief Risk OfficerOrganization not published
   E5
3. 2026 to end not published
   Executive title: President and Chief Executive OfficerOrganization not published
   E4
4. 2026 to end not published
   Executive title: Senior Vice President and Services General ManagerOrganization not published
   E6
5. 2026 to end not published
   Executive title: Executive Vice President and Chief Legal and Administrative OfficerOrganization not published
   E7E10

No education, credentials, or certifications are published in this record.

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
• Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
• Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
• Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Each relationship is one Claim rendered on every record it connects.

• P
  PfizerDirector, 2007 to present
  person:suzanne-nora-johnson:role:1
• N
  NvidiaDirector, Current · dates not published
  person:suzanne-nora-johnson:role:2
• ON
  Organization not publishedExecutive title: President, 2026 to end not published; Executive title: Executive Vice President, Chief Administrative Officer and Chief Risk Officer, 2026 to end not published; Executive title: President and Chief Executive Officer, 2026 to end not published; Executive title: Senior Vice President and Services General Manager, 2026 to end not published; Executive title: Executive Vice President and Chief Legal and Administrative Officer, 2026 to end not published
  person:suzanne-nora-johnson:executive_title:19, person:suzanne-nora-johnson:executive_title:18 +3

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis

Public role at an organization in the published Registry

Sources

12 evidence records cited. 0 with redistribution rights.

Never published

Home address, family, personal contacts, health, and history unrelated to the public role

Profile claimed

No

Open disputes

0

Identity ownership

unclaimed

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

1. E1
   ASO 10-K executive officers

   SEC EDGAR. sec filing. Published Mar 17, 2026. Retrieved May 14, 2026. Cited by 5 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
2. E2
   PFE DEF 14A director slate

   SEC EDGAR. sec filing. Published Mar 12, 2026. Retrieved Apr 30, 2026. Cited by 5 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   Pfizer director board source

   SEC EDGAR. sec filing. Published Mar 12, 2026. Retrieved May 3, 2026. Cited by 4 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   SDRL 10-K executive officers

   SEC EDGAR. sec filing. Published Feb 26, 2026. Retrieved May 5, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   UMBF 10-K executive officers

   SEC EDGAR. sec filing. Published Feb 26, 2026. Retrieved May 5, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   UCTT 10-K executive officers

   SEC EDGAR. sec filing. Published Feb 23, 2026. Retrieved May 5, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
7. E7
   CMS 10-K executive officers

   SEC EDGAR. sec filing. Published Feb 10, 2026. Retrieved May 2, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
8. E8
   Source title not published

   sec filing. Published Jan 1, 2007. Retrieved May 3, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
9. E9
   Source title not published

   alpha profile factory. Retrieved Aug 11, 2026. Cited by 1 Claim.
   Open web
   Rights not recorded, link only
   Evidence not pinned
10. E10
    CMS executive roster source

    SEC EDGAR. sec filing. Retrieved May 3, 2026. Cited by 5 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
11. E11
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
12. E12
    Source title not published

    public source. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned

• Suzanne Nora Johnson seat on Pfizer, effective 2007-01-01.